UCP1 and colonic neoplasm: Chromanes inhibit basal proton conductance of UCP1 and UCP2 and sensitise HT-29 colon cancer cells to commonly used chemotherapeutic agents such as cisplatin and doxorubicin (Rial et al, 2011).